Ranatuerin-2Pb (1-16)

General Information


DRACP ID  DRACP03850

Peptide Name   Ranatuerin-2Pb (1-16)

Sequence  SFLTTVKKLVTNLAAL

Sequence Length  16

UniProt ID  A9CBH5 

PubChem CID  Not available

Origin  Synthetic

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antibacterial; Antifungal



Structure Information


PDB ID  Not available

Predicted Structure  Not available

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Amidation

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C80H139N19O22

Absent amino acids  CDEGHIMPQRWY

Common amino acids  L

Mass  198684

Pl  10.81

Basic residues  2

Acidic residues  0

Hydrophobic residues  9

Net charge  2

Boman Index  551

Hydrophobicity  98.75

Aliphatic Index  146.25

Half Life 
  Mammalian: 1.9 hour
  Yeast: >20 hour
  E.coli: >10 hour

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  5

Amino acid distribution



Literature Information


Literature 1

Pubmed ID 31242693

Title  Bioevaluation of Ranatuerin-2Pb from the Frog Skin Secretion of Rana pipiens and its Truncated Analogues

Doi Not available

Year  2019

Patent

Patent ID Not available

Patent Title  Not available

Other Iinformation  Not available

Other Published ID  Not available




DBAASP ID  13626

DRACP is developed by Dr.Zheng's team.